Arzneiwerk AG VIDA (FRA:TLIK)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Core Solutions	68.54K	207.10K	-	-	2.52M
Core Solutions Growth	-66.91%	-	-	-	-10.58%
Pharma	-	-	1.31M	73.37M	-
Pharma Growth	-	-	-98.21%	-	-
Total	68.54K	207.10K	1.31M	73.37M	2.52M
Total Growth	-66.91%	-84.20%	-98.21%	2811.40%	-10.58%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Germany	39.74M	-
Denmark	16.21M	-
Great Britain	11.72M	-
Austria	2.02M	-
Switzerland	1.65M	-
Other Foreign Countries	2.03M	-
DACH	-	1.38M
DACH Growth	-	19.57%
Europe	-	637.00K
Europe Growth	-	-32.59%
Middle East	-	314.00K
Middle East Growth	-	-10.29%
Other	-	35.00K
Other Growth	-	-53.33%
Total	73.37M	2.36M
Total Growth	3007.69%	-6.31%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 16, 2026

Data Sources Report a data error